Ameriprise’s LIPOSCIENCE INC COM LPDX Stock Holding History

Ameriprise’s Portfolio LPDX Stock Details LPDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-250	Closed	-$1K	–	5716
2013 Q3	$1K	Buy	+250	New	+$1.4K	﹤0.01%	5529

Other funds holding LPDX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

IPC

Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise's LPDX Position: Q4 2013 in Review

Ameriprise sold out of LIPOSCIENCE INC COM (LPDX) in Q4 2013, closing a stake of 250 shares — an estimated $1K sold.

Ameriprise first reported a position in LPDX in Q3 2013 and held it in 1 quarter. The position peaked at $1K in Q3 2013. 30 funds tracked by Wall St. Rank hold LPDX as of Q4 2013.

Ameriprise reported no remaining LIPOSCIENCE INC COM position as of Q4 2013 after selling out during the quarter.
Ameriprise sold 250 LIPOSCIENCE INC COM shares in Q4 2013, an estimated $1K.
Ameriprise first reported a position in LIPOSCIENCE INC COM in Q3 2013 and held it in 1 quarter.
Ameriprise's LIPOSCIENCE INC COM position peaked at $1K in Q3 2013.
30 funds tracked by Wall St. Rank held LIPOSCIENCE INC COM as of Q4 2013.

Based on Ameriprise's 13F filing for Q4 2013, filed 14 Feb 2014.